These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3868621)

  • 1. Phase II of ACNU for non-small cell lung cancer.
    Sasaki Y; Saijo N; Shimizu E; Eguchi K; Shinkai T; Tominaga K; Sakurai M; Ishizuya Y; Fujita J; Futami H
    Eur J Cancer Clin Oncol; 1985 Dec; 21(12):1557-9. PubMed ID: 3868621
    [No Abstract]   [Full Text] [Related]  

  • 2. Phase II trial of nimustine (ACNU; 3-[4-amino-2-methyl-5-pyrimidinyl) methyl]-1-(2-chloroethyl)-1-nitrosourea hydrochloride) in patients with small cell carcinoma of the lung after failure on combination chemotherapy.
    Joss RA; Siegenthaler P; Ludwig C; Alberto P; Castiglione MM; Cavalli F
    Invest New Drugs; 1986; 4(2):175-9. PubMed ID: 3015827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of ACNU on primary lung cancer, mesothelioma, and metastatic pulmonary tumors.
    Saijo N; Nishiwaki Y; Kawase I; Kobayashi T; Suzuki A; Niitani H
    Cancer Treat Rep; 1978 Jan; 62(1):139-41. PubMed ID: 626992
    [No Abstract]   [Full Text] [Related]  

  • 4. Phase II trial of 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea in small cell cancer of the lung.
    Chapman RA; Natale RB; Young CW; Wittes RE
    Am J Clin Oncol; 1984 Oct; 7(5):413-4. PubMed ID: 6095639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical evaluation of two combination chemotherapies for the treatment of small cell carcinoma of the lung.
    Kutsuzawa T; Hayashi Y; Kurata T; Kobayashi R; Kondo T; Sonoda Y; Takasaki Y; Shioya S; Yamauchi T; Tamaya S
    Tokai J Exp Clin Med; 1984 Dec; 9(5-6):363-9. PubMed ID: 6100629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of nitrosourea glycosyl analogs--V. An oriented phase II trial of RFCNU.
    Mathe G; Schein P; MacDonald JS; Imbach JL; Misset JL; De Vassal F; Ribaud P; Serrou B; Gouveia J; Musset M; Machover D; Schwarzenberg L; Jasmin C; de Jager R
    Eur J Cancer Clin Oncol; 1982 Aug; 18(8):727-32. PubMed ID: 6891323
    [No Abstract]   [Full Text] [Related]  

  • 7. Phase II study of CCNU (NSC-79037) in the treatment of advanced gastrointestinal cancer.
    Klaassen DJ; Rapp E
    Cancer Chemother Rep; 1974; 58(5 Pt 1):667-9. PubMed ID: 4426046
    [No Abstract]   [Full Text] [Related]  

  • 8. Trial of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU; NSC-79037) in advanced bronchogenic carcinoma 1,2,3.
    Stolinsky DC; Bull FE; Pajak TF; Bateman JR
    Oncology; 1975; 31(5-6):288-92. PubMed ID: 174040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proceedings: Superiority of adriamycin over oral nitrosoureas in patients with advanced breast carcinoma. A Southwest Cancer Chemotherapy study Group study.
    Gottlieb JA; Rivkin SE; Spigel SC; Hoogstraten B; O'Bryan RM; Delaney FC; Singhakowinta A
    Cancer; 1974 Feb; 33(2):519-26. PubMed ID: 4812769
    [No Abstract]   [Full Text] [Related]  

  • 10. [The treatment of psoriasis. Critical study of the use of ACNU (nimustine hydrochloride)].
    Imaizumi T; Mitsuhashi Y; Katabira Y
    Ann Dermatol Venereol; 1986; 113(5):427-34. PubMed ID: 3472485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental and clinical effect of ACNU in Japan with emphasis on small-cell carcinoma of the lung.
    Saijo N; Niitani H
    Cancer Chemother Pharmacol; 1980; 4(3):165-71. PubMed ID: 6249513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1,-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (methyl CCNU) and adriamycin combination therapy.
    Lokich JJ; Skarin AT; Frei E
    Cancer; 1974 Nov; 34(5):1593-7. PubMed ID: 4426026
    [No Abstract]   [Full Text] [Related]  

  • 13. Phase I trial of PCNU.
    Kalman LA; Gralla RJ; Casper ES; Kris MG; Gordon C; Woodcock TM
    Cancer Treat Rep; 1983 Nov; 67(11):1027-9. PubMed ID: 6315229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Advances on ACNU in the past 10 years].
    Niitani H
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 1):727-31. PubMed ID: 3281592
    [No Abstract]   [Full Text] [Related]  

  • 15. [Phase II study of the water-soluble nitrosourea compound ACNU in advanced colorectal carcinomas].
    Fiebig HH; Wellens W; Peukert M; Henss H; Arnold H; Westerhausen M; Löhr GW
    Onkologie; 1984 Dec; 7(6):370-7. PubMed ID: 6396565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II study of fotemustine in untreated inoperable non-small-cell lung cancer.
    Rudd R; Allen R; Berille J; Spiro SG; Trask C; Souhami RL
    Cancer Chemother Pharmacol; 1994; 34(5):444-6. PubMed ID: 8070014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A trial of 1-(2-chlorethyl)-3-(4-methyl-cyclohexyl)-1-nitrosourea in the treatment of patients with advanced gastro-intestinal cancer.
    Giles GR; Hall R; Brennan TG; Worthy TS
    Br J Surg; 1974 Dec; 61(12):950. PubMed ID: 4140746
    [No Abstract]   [Full Text] [Related]  

  • 18. Phase II study of nimustine in metastatic soft tissue sarcoma. European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.
    Wagener DJ; Somers R; Santoro A; Verweij J; Woll PJ; Blackledge G; Schütte HJ; Lentz MA; van Glabbeke M
    Eur J Cancer; 1991; 27(12):1604-5. PubMed ID: 1782068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1-2(2-Chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU, NSC-79037): a comparison of drug administration at four-week and six-week intervals.
    Broder LE; Hansen HH
    Eur J Cancer (1965); 1973 Feb; 9(2):147-52. PubMed ID: 4717488
    [No Abstract]   [Full Text] [Related]  

  • 20. Phase II multicentre study of the nitrosourea fotemustine in inoperable squamous cell lung carcinoma.
    Le Chevalier T; Zabbe C; Gouva S; Cerrina ML; Quoix E; Riviere A; Berthaud P; Prache C; Berille J
    Eur J Cancer Clin Oncol; 1989 Nov; 25(11):1651-2. PubMed ID: 2687005
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.